Loading...
A PHASE I STUDY OF INTRAVENOUS OR INTRAPERITONEAL PLATINUM BASED CHEMOTHERAPY IN COMBINATION WITH VELIPARIB AND BEVACIZUMAB IN NEWLY DIAGNOSED OVARIAN, PRIMARY PERITONEAL AND FALLOPIAN TUBE CANCER
BACKGROUND: Improvements in disease free survival for epithelial ovarian, peritoneal or fallopian tube cancer (EOC) will only come with improved primary therapy. Incorporation of poly-ADP-ribose inhibitors (PARPi) in the frontline setting may represent one strategy. This study sought to determine th...
Na minha lista:
| Udgivet i: | Gynecol Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7048389/ https://ncbi.nlm.nih.gov/pubmed/31708167 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2019.10.012 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|